Revisiting Estrogen: Efficacy and Safety for Postmenopausal Bone Health
The rapid decline in endogenous estrogen production that occurs during menopause is associated with significant bone loss and increased risk for fragility fracture. While hormone therapy (HT) is an effective means to re-establish endogenous estrogen levels and reduce the risk of future fracture, its...
Saved in:
Main Authors: | Sandra M. Sacco, Wendy E. Ward |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.4061/2010/708931 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship between Postmenopausal Estrogen Deficiency and Aneurysmal Subarachnoid Hemorrhage
by: Sadaharu Tabuchi
Published: (2015-01-01) -
Exploration of the metabolomic mechanisms of postmenopausal hypertension induced by low estrogen state
by: Yao Li, et al.
Published: (2025-01-01) -
The Significance of ST Depression in a Postmenopausal Woman on Estrogen Therapy during Regadenoson Myocardial SPECT Imaging
by: Nishaki Kiran Mehta, et al.
Published: (2015-01-01) -
Dual disease co-expression analysis reveals potential roles of estrogen-related genes in postmenopausal osteoporosis and Parkinson’s disease
by: Dongdong Yu, et al.
Published: (2025-01-01) -
Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
by: Marouane Boukhris, et al.
Published: (2014-01-01)